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Abstract
Background: Influenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional
jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza
epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal
antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity.
Methodology/Principal Findings: We test the role of glycoprotein charge on sequence data from the three major subtypes
of influenza A in humans, using a simple method of calculating net glycoprotein charge. Of all subtypes, H3N2 in humans
shows a striking pattern of increasing positive charge since its introduction in 1968. Notably, this trend applies to both
hemagglutinin and neuraminidase glycoproteins. In the late 1980s hemagglutinin charge reached a plateau, while
neuraminidase charge started to decline. We identify key groups of amino acid sites involved in this charge trend.
Conclusions/Significance: To our knowledge these are the first indications that, for human H3N2, net glycoprotein charge
covaries strongly with antigenic drift on a global scale. Further work is needed to elucidate how such charge interacts with
other immune escape mechanisms, such as glycosylation, and we discuss important questions arising for future study.
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Introduction
The influenza A virus is a prominent example of a pathogen
capable of adapting to evade host immunity [1,2], with profound
implications for epidemiology and control. Hence, for example,
seasonal influenza vaccines need to be updated frequently, to
maintain protection in risk-groups against currently circulating
strains [3].
Immunity to influenza is mediated predominantly by neutral-
izing antibodies raised against two surface glycoproteins, hemag-
glutinin (HA) and neuraminidase (NA) [4]. Antigenic ‘drift’ refers
to the incremental adaptations in these antigens from year to year,
forming the basis for immune evasion. However, while phenom-
enological characteristics of drift have been well-characterised
[5,6], the key molecular and evolutionary determinants of immune
escape remain incompletely understood.
Amino acid substitutions directly reducing or abolishing
antibody recognition of major epitopes are likely to be the
predominant part of immune escape [7]. Glycosylation - the post-
transcriptional acquisition of carbohydrate side-chains - can have
the additional effect of ‘masking’ epitopes from antibody
recognition [8], but at a cost: heavily glycosylated viruses are
also more susceptible to capture by the host innate immune
system [9].
A recent study [10], using challenges of vaccinated and naı ¨ve
mice, has highlighted another, potentially significant element of
the immune escape repertoire: the selection of ‘adsorptive
mutants’, showing enhanced binding to target cells. Demonstrat-
ing a strong association between immune escape and avidity for
target cells, this study suggests that viral replication success
depends on a competition between host-cell binding, and
engagement by neutralizing antibodies. Conversely, however,
naı ¨ve mice show positive selection for reduced avidity, indicating
that this strategy of immune escape also carries a fitness cost – this
may be due, for example, to high-avidity progeny virions being
released less efficiently from host cells.
A notable aspect of avidity demonstrated in this study is that of
electrostatic charge – several immune escape mutants show an
increased positive charge in HA. From a molecular standpoint,
since host cell receptors possess a strong negative charge, virions
with a higher net positive charge may tend to promote favourable
electrostatic interactions with target cells [11].
The role of electrostatic charge has been appreciated for other
human viruses: a notable example is HIV, where a viral phenotype
associated with rapid progression to AIDS is distinguished from
those associated with early stages of HIV-infection by the presence
of charged residues at two amino acid positions on the V3 region
of the gp120 subunit [12]. However, the potential relevance of
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tively little attention.
Thus motivated, we ask the following questions: considering
epidemic influenza in humans, is there any indication for the role of electrostatic
charge in viral evolution? How might these relate to observed patterns of
antigenic drift, most notably for the subtype H3N2? Specifically (in line with
[10], is increasing immune escape during antigenic drift associated with an
increase in viral surface charge? We address these questions by
exploring secular changes in the net charge on HA and NA
molecules revealed by amino acid sequences from published
influenza databases. We present a striking pattern of coherent
charge accumulation. In contrast with the HIV-V2 protein this
pattern involves at least 20 amino acid sites across the length of the
hemagglutinin sequence, with a correspondingly greater degree of
net charge change accumulated over several decades. Overall,
while these observations are not definitive of the role of electric
charge in immune escape, they cast light on intriguing, hitherto
unreported phenomena, calling for further experimental study.
We discuss important questions arising for further investigation.
Methods
At physiological pH, protein-associated amino acids are
generally charge-neutral, with five exceptions: Arginine, Histidine
and Lysine are ionized with a single positive net charge, while
Aspartic acid and Glutamic acid are ionized with a single negative
net charge [13]. Given the amino acid sequence for a certain
glycoprotein, we may then calculate overall net charge, to a first
approximation, simply by summing charge contributions from all
of these constituents. In the discussion section we return to qualify
the assumption of physiological pH for all amino acids in the
sequence.
Sequences for HA and NA were obtained from the NIAID
influenza database [14], with the restriction of being full-length to
avoid potential biases due to variable sampling of amino acid
positions. Identical sequences in the same year were collapsed to a
single one, to avoid biases due to over-representation of certain
samples in the database. Net glycoprotein charge was then
calculated for each sequence, using the approach described above.
Results
Figure 1 shows charge plotted against year of sampling, for the
three major subtypes of human influenza: H1N1 (1977–2008),
H2N2 and H3N2. There is no apparent pattern for the first two.
For the H3N2 subtype, however, charges for both HA and NA
show clear increasing trends following introduction of this virus in
the Hong Kong pandemic of 1968. Intriguingly this trend changes
for both HA and NA in the same year, in 1986. After this point
HA charge appears to plateau, while NA charge undergoes a noisy
decline.
A potential difficulty with this data set is the variability of viral
sampling through time, as illustrated by the size of the points in
figure 1 and as plotted in Figure S1. In particular, there is a
paucity of full-length sequences collected in the mid-1970s.
Nonetheless, a linear regression of charge against year offers a
simple approach for testing the statistical support for an increasing
HA charge, while allowing for widely varying sample sizes from
year to year. Such an approach yields a significance level of
p,0.0001, for both HA and for NA. An alternative approach is to
choose just two years for comparison, using a t-test to assess
support for a statistically significant difference in mean charge
from the first timepoint to the second. Applying this to data from
1968 (23 samples) and 1993 (32 samples) once again gives a
significance level of p,0.0001, for both HA and NA. Despite the
patchiness of data, therefore, there is sufficient evidence to suggest
a significant increase in charge between 1968 and 1992.
The HA monomer is an assembly of two subunits: HA1
contains the globular head of the HA molecule, while HA2
contains the stalk region, and is attached to the viral membrane.
To explore whether changes in charge occur preferentially in
either of these subunits, the procedure above is repeated for the
relevant segments of the HA amino acid sequence. Results shown
in Figure 2 indicate that the bulk of the charge changes occurred
in the HA1 subunit, as might be expected: containing the receptor
binding site, this region is most directly involved in attachment to
host cells. Thus (as predicted by [10]), H3N2 charge increases in
parallel with net antigenic escape, at least over the early part of the
virus’s history in humans.
It is, of course, possible that this observed trend is only a by-
product of HA evolution, without any independent antigenic
relevance. To explore this possibility the same charge analysis was
applied to NS1 [15], another influenza viral component showing
rapid evolution [16], but without the antigenicity of HA or NA in
natural infection. NS1 is expressed as a protein only in the
intracellular stage of the replication cycle, with the function of
antagonising host innate antiviral responses, as well as playing an
important role in regulating transcription. Figure 3 plots charge
variation of NS1 restricted to human H3N2, showing no
significant temporal trend, despite the rapid evolution of this viral
component. Hence it would appear that the coherent temporal
trends observed for HA and NA are more than simply a by-
product of protein evolution.
Returning to the HA1 subunit of Hemagglutinin, we ask which
set of amino acid positions accounts for the most temporal
variation in charge, with a view to comparing these against known
features of H3N2 evolutionary history. As noted earlier (see figure
S1), the number of amino acid sequences available from GenBank
is itself variable in time. To avoid artefacts from years with little or
no viral sampling we restrict attention to a comparison between
samples in 1968, 1985 and 2000, timepoints having 45, 35 and
249 samples respectively.
Figure S2 plots the estimated probability of an amino acid site
showing positive or negative charge, plotted along the length of the
HA1 sequence in 2000. With three exceptions, sites tend to show
clearly dominant charge states (whether positive, neutral or
negative) and charge transitions at given sites tend to be
characterized by population-level ‘switches’ from one state to
another. This is perhaps not surprising, given the comparatively
limited population-level diversity of influenza in any given year
[17].
As one possible partitioning of amino acid sites, those sites that
have undergone a change in charge state from 1968 to 2000 are
designated as ‘group 1’. Further, we define ‘group 2’ sites as those
showing a change in charge between 1968 and 1985, followed by a
reversion between 1985 and 2000, thus resulting in zero net
charge difference over the whole time period. Amino acid sites
belonging to these two groups are summarized in table 1.
Figure 4 plots charge trends when summed separately over these
sets of amino acids, showing clear qualitative and quantitative
differences between them. Group 1 amino acids together show a
continuous, steady increase in total charge, accounting for the
greatest temporal variation between 1968 and 2000. However,
panel C demonstrates that incorporating group 2 amino acids
accounts for the plateau in total HA charge reached in the early
1990s. The lack of temporal variability in panel D suggests that
groups 1 and 2 together capture the essential secular charge
variation shown by the whole HA molecule. While it remains
unclear what biological relevance – if any – these groupings may
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could be relevant in explaining the change in charge trend in the
late 1980s.
The right-hand panel of figure 4 shows a visualization of group
1 and 2 amino acid positions on the HA1 structure [18]. A notable
feature is the clustering of several of these positions around the
receptor binding site (shown in green), the active site for binding
with target cell sialic acid. As we might expect, most of these are
group 1 positions undergoing a positive charge transition (shown
in blue) between 1968 and 2000. Conversely, sites undergoing a
negative transition (shown in red) are – with one exception – all
further down the HA length.
Figure 1. Timecourses of total charge of the major antigens HA and NA. Shown for three main human subtypes of influenza A. Sizes of dots
represent frequencies, as indicated in the legend. Increase in positive charge for both H3N2 glycoproteins is statistically significant (p,0.0001 in both
cases).
doi:10.1371/journal.pone.0015674.g001
Figure 2. Comparison of changes in charge in the two subunits of the H3N2 HA molecule. Solid lines indicate mean trends. The side-bar
illustrates these regions on the HA molecule (diagram source: RCSB Protein Data Bank).
doi:10.1371/journal.pone.0015674.g002
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A natural hypothesis arising from [10] is that H3N2 charge
covaries with other immune escape mechanisms already known to
have been significant in H3N2 evolutionary history. We now
explore possible connections with two notable features of H3N2
evolution, namely punctuated antigenic drift, and the accumula-
tion of glycosylation sites.
H3N2 antigenic drift is characterized by stepwise antigenic
changes that occur every 2–8 years [5], against a background of a
relatively steady rate of amino acid substitutions. Thus H3N2
viruses show grouping into antigenic ‘clusters’, contiguous but
overlapping in time. Amino acid substitutions in HA associated
with transitions from one cluster to another have previously been
identified: calculating the charge contribution from each of these
over time (table 2) shows that charge effects ranged from 22t o+3.
However, the net change arising from antigenic cluster transitions
since 1968 is +1, accounting for only a small part of the total
increase of almost +10 that occurred throughout HA during this
same period. Thus, on an aggregate level, there is no simple
connection between charge and cluster transitions.
On the level of individual amino acid positions, there are
nonetheless some suggestive results: all group 2 amino acids are
also implicated in cluster transitions, with their charge switches
coinciding with the timing of those jumps. About half of group 1
amino acid sites are involved in cluster transitions. Of these, site
145 is prominent for having the potential to cause unusually large
antigenic change, being the sole site involved in two separate
cluster transitions [5], in both cases undergoing an increase in
positive charge (see table 2). However, further work is needed to
elucidate the significance – if any – of these apparent connections.
Another unique feature of human H3N2 evolutionary history is
the steady accumulation of potential N-linked glycosylation sites
through time. Such positions are characterised by NXS/T
sequons, with X being any amino acid other than Proline. Human
H3N2 is unique among influenza A subtypes for accumulating
potential glycosylation sites since 1968 [19,20], with evidence that
this is in response to selection pressure [21]. There are indeed
tangible reasons to expect that glycosylation may interact with
charge locally on the HA surface: glycans positioned near the
receptor binding site can lower affinity for host cells [22–24] and
thus increasing positive charge near the glycosylation site could
have a compensatory role by mitigating this effect. Alternatively
complex glycans may themselves carry a negative charge, by virtue
of attached sialic acid, whose effect could again be mitigated by the
presence of positive charges near the glycosylation site.
Figure 5 shows the approximate timing of acquisition and loss of
glycosylation sequons in HA1 sequences, comparing against the
dominant charge states of group 1 and 2 amino acids. In
accordance with [19–21], the upper panel shows a steady increase
in the number of glycosylation sites with time. There are indeed
amino acid sites that underwent both a positive charge transition
and the acquisition of a potential glycosylation site, such as 63,
276, and the region 81–83. However, such events at these sites are
not necessarily synchronous, most apparently being separated by
several years, and thus there is no clear causal connection. Further
data is needed to explore the possibility of more subtle connections
between glycosylation and charge.
We can extend this general analysis to glycoprotein charge in
non-human hosts, as detailed in the Appendix. In particular,
Figure S3 suggests that H3 HA charge in avian hosts has been
relatively stable since 1970, at a level in agreement with that of
human H3 in its introduction in 1968. This is indeed as we might
expect, given the avian origin of H3 in humans. Figure S4
broadens this search to other subtypes and host species, illustrating
that none show a coherent pattern comparable to human H3N2.
Discussion
Conformational changes in epitopic regions undoubtedly play
an important – perhaps dominant – role in inhibiting binding by
neutralising antibodies. Recent experiments show that the
enhancement of avidity for host cells is also a potentially potent
mechanism [10]. Here we have demonstrated clear indications
that, in the specific case of H3N2, the virus has undergone
increasing positive charge since its introduction in humans.
Equally intriguing is the apparent uniqueness of this pattern, to
H3N2 in humans. Indeed, it is perhaps no coincidence that human
H3N2 is a paradigm of antigenic drift, showing an unrivalled
tempo and extent of antigenic variation in comparison with other
known influenza subtype/host combinations [4].
Some important caveats are in order here: first, there are
alternative interpretations for the patterns we observe. For
instance, it may well be the case that charge increments are only
an incidental effect of substitutions whose primary antigenic
impact is a conformational change at active sites. Related to this
point, it must be noted that charge is not a necessary feature for
increasing avidity, and is therefore only one of several potential
Figure 3. Charge data for the influenza NS1 protein. Restricted
to the H3N2 subtype.
doi:10.1371/journal.pone.0015674.g003
Table 1. Amino acids of the HA1 sequence involved in
changes of charge state when comparing 1968, 1985 and
2000.
2000
1968 Positive (+) Neutral Negative (2)
Positive (+) — 57/156 —
Neutral 142/145/155/158/
160/173/276
189/197 53/62/83/188
Negative (2) 2/82 31/63/275 172
‘Group 2’ amino acids, as defined in the main text, are shown in italics on the
diagonal – all three exhibited an increase in charge of +1 in 1985, followed by a
reversion before 2000. All other amino acids belong to ‘group 1’. Note that
those elements below the diagonal contribute to a positive overall charge, and
vice versa for those above the diagonal.
doi:10.1371/journal.pone.0015674.t001
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the key message of our results is simple: given the complexity and
sheer multiplicity of interacting host and viral factors in viral
immune escape, it is striking that such a simple measure of charge
should yield such a marked pattern in the global database over
several decades. Particularly in the light of previous results of the
role of avidity in immune escape [10], we believe the phenomena
we have demonstrated here form a basis for testable hypotheses
warranting further investigation.
Regarding our simple algorithm for calculating net charge, an
assumption requiring some care is that of amino acids being
subject to physiological pH. While this is likely to apply for surface
residues, those residues internal to the HA structure may instead
be associated with significantly altered pKa values. Nonetheless,
the HA1 structure shown in figure 4 indicates that such effects
would not be expected to significantly alter our results. It illustrates
that all group 1 and 2 amino acids are surface residues, and indeed
summing charge over these positions alone reproduces the
essential secular trend in figure 1 for the whole HA molecule.
The biological significance of these identified sites remains
unclear. Moreover, at this point we can only speculate about
connections between charge, glycosylation and antigenic cluster-
ing. It is relevant to note that there is yet no clear indication of a
systematic relationship between H3N2 glycosylation and antigenic
Figure 4. Charge trends when summed separately over ‘group 1’ and ‘group 2’ amino acids (see table 1). This approach shows that
certain sites, which reverted charge state between 1985 and 2000, may account for the ‘plateau’ in total HA charge observed over this time. The right-
hand panel locates the amino acids on the HA structure, showing the receptor binding site in green; group 1 positions showing a positive transition
(in blue); group 1 positions showing a negative transition (in red); and group 2 positions, showing a transition followed by a reversion in a
subsequent year (in magenta).
doi:10.1371/journal.pone.0015674.g004
Table 2. Amino acid substitutions accompanying antigenic jumps, and their associated charge changes (see [5]).
Year Amino acid substitutions Overall charge effect
1972 T122N; (G144D); T155Y; (N188D); R207K 2 2
1975 N137S; S145N; L164Q; Q189K;( S193D); (N53D); I278S; F174S; R102K; I213V; I217V; I230V 1 2
1977 S137Y; (G158E); Q164L; D193N; K50R; D53N; S174F; K201R; V213I; V230I; E82K; M260I 3 +
1979 N133S; P143S; G146S; (K156E); T160K; Q197R;( N53D); N54S; D172G; V217I; V244L; 162K;( K82E)1 2
1987 (G124D); Y155H;K 1 8 9 R 0
1989 N145K 1 +
1992 (S133D); (K145N); E156K; E190D 0
1995 N145K 1 +
1997 (K156Q); E158K; V196A; N276K;( K62E); 0
2002 A131T; (H155T); Q156H;( R50G); (H75Q); E83K; L25I; V202I; W222R;( G225D)0
While successive antigenic groups overlap in time, ‘year’ denotes the timing of the first vaccine strain incorporating the given substitutions. Substitutions shown in bold
denote a net positive change, and vice versa for those in parentheses.
doi:10.1371/journal.pone.0015674.t002
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conducted here do not yield any immediate relationships with
charge. Clearly, however, this preliminary analysis addresses only
the simplest hypotheses and says little about the possibility of more
subtle interactions. For example, such interactions may be
expressed on an aggregate scale: given the comparative sizes of
virion and host cell it is possible that for most relevant dynamics
the virion acts as a point charge on the physical scale of the cell,
characterized more by its net charge than by the distribution of
that charge on its surface. More detailed studies of virus-cell
interactions in the presence of antibodies would clearly help to
resolve questions like these. Furthermore, assays of binding kinetics
of viral samples since 1968 will be essential in confirming whether
the charge trend demonstrated here does in fact accompany an
increase in H3N2 avidity for host cells.
A prominent, unexplained feature of H3N2 glycoprotein charge
behaviour is the change in trend, for HA and NA alike, occurring
in 1986. It is unclear whether this arises from a change in selection
pressure, or from functional constraints on the virus – it is possible,
for example, that an upper limit on the total virion charge is
required for structural stability. Our preliminary analysis does not
suggest any general, direct connection with observed antigenic
cluster transitions for H3N2. It is, however, perhaps relevant that a
cluster transition occurred in 1987, at about the same time as the
shifts in the charge trends. This particular event is notable for at
least two reasons: first, it marked the end of an unusually long
period free of cluster transitions [5]. Second, in ‘antigenic space’
(as measured by hemagglutination inhibition assays with ferret
sera), early antigenic variation proceeded in a predominantly
linear fashion from the ancestral, 1968 strain. The transition in
1987 was unusual in breaking this linear trend for the first time [5],
possibly showing higher cross-reactivity with previous strains as a
result. If indeed relevant, both of these scenarios would point to a
role of shifting selection pressure, in the changing trends in charge
following 1987.
In addition to the issues raised above, several other potential
avenues for future work arise from our observations. While the link
between avidity and immune escape has been demonstrated [10],
an important question for future experimental study is how these
effects translate to viral transmission and hence fitness. A natural
extension of existing work would be a study of serial infection or
transmission, to allow the accumulation of immune escape
mutations over many generations. Virological questions include:
is there an inherent limit on the charge that a viral structure can
support? How does a virus offset replication costs owing to greater
avidity? Interestingly, there were no signs of co-adaptation of NA
in [10]. Are there limits on NA function that would explain this?
In its entirety the influenza immune escape repertoire
undoubtedly involves several mechanisms, and it is likely that
these mechanisms interact. Ultimately, therefore, it is probable
Figure 5. Estimated timing of major charge and glycosylation events. In the lower panel, grey bars denote the presence of an N-
glycosylation sequon in at least 10% of sequences in a year. Note that where there are only few samples in a year, as depicted in Figure S1, estimates
in both panels become less reliable.
doi:10.1371/journal.pone.0015674.g005
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only be adequately understood in conjunction with other, parallel
processes, such as glycosylation. Nonetheless, the prominent
patterns we have discussed here point to a potentially significant
role for glycoprotein charge, deserving further elucidation.
Supporting Information
Figure S1 Number of HA1 amino acid sequences
available from GenBank, as a function of time.
(TIF)
Figure S2 The probability distribution of charge states
occupied by each amino acid position in the HA1
sequence, in the year 2000. The majority of points lie along
the edges, indicating a strong dominance of the corresponding
charge state at those sites.
(TIF)
Figure S3 HA charge distribution in avian hosts, for H3
viruses. The figure above was obtained using all 364 full-length
avian H3 virus sequences in the NIAID influenza database [14].
Of these, the majority (349) lie in the charge range +4t o+9.
Chickens, as poultry, are considered one of the possible routes of
introduction of novel human influenza viruses. All sequences from
chickens had charge from +6t o+7. There is a clear species-related
structure in the remaining 15 samples: 11 were from turkeys, 1
from a northern pintail, and 3 from mallards. Conversely,
sequences isolated from turkeys all had charges +10 or greater.
An explanation for the consistent anomaly of turkey viruses is that
most of these samples arose from two separate studies implicating
swine in the introduction of H3N2 into turkey farms [26,27]. As
shown in Figure S4, the charge levels of HA in swine H3N2 in
2004 are in line with those observed in turkeys at about the same
time, above.
(TIF)
Figure S4 HA and NA charge distribution for two
illustrative subtype/host species pairs. Other subtypes,
and hosts, show a comparable behaviour, with no discernible
pattern over time.
(TIF)
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